We found that YY1 suppressed PGC-1β transcription by directly binds to its promoter, resulting in subsequent suppression of MCAD and LCAD levels and decreased fatty acid β-oxidation irrespective of HIF-1α status. The gene discussed is YY1; the disease is long chain acyl-CoA dehydrogenase deficiency.